Home › Companies › Lifecore Biomedical, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Lifecore Biomedical, Inc.’s Form 8-K, filed June 5, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 4, 2026: 10 items on Lifecore Biomedical, Inc.’s Form 8-K, filed June 5, 2026: 3 approved · 7 without a stated outcome.
Meeting of October 29, 2025: 9 items on Lifecore Biomedical, Inc.’s Form 8-K, filed October 31, 2025: 2 approved · 7 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore Lifecore Biomedical, Inc. in the interactive database Compare manager voting policies
These tallies are Lifecore Biomedical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. Lifecore Biomedical, Inc. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Katrina L. Houde | 19,790,359 | 3,336,694 | -- | 3,350 | 10,697,326 | 86% | Not verified | — |
| Elect Director: Humberto C. Antunes | 21,713,661 | 1,408,873 | -- | 7,869 | 10,697,326 | 94% | Not verified | — |
| Elect Director: Paul H. Johnson | 21,920,254 | 1,206,182 | -- | 3,967 | 10,697,326 | 95% | Not verified | — |
| Elect Director: Paul Josephs | 23,068,707 | 57,729 | -- | 3,967 | 10,697,326 | 99.7% | Not verified | — |
| Elect Director: Matthew E. Korenberg | 21,432,586 | 1,693,825 | -- | 3,992 | 10,697,326 | 93% | Not verified | — |
| Elect Director: Nelson Obus | 21,450,647 | 1,675,206 | -- | 4,550 | 10,697,326 | 93% | Not verified | — |
| Elect Director: Joshua E. Schechter | 20,394,278 | 2,731,575 | -- | 4,550 | 10,697,326 | 88% | Not verified | — |
| 2. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026, with votes | 33,760,879 | 63,445 | 3,405 | -- | -- | 99.8% | Approved | — |
| 3. The compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes | 22,938,684 | 178,868 | 12,851 | -- | 10,697,326 | 99.2% | Approved | — |
| 4.Stockholders approved the Lifecore Biomedical, Inc. | 22,724,492 | 392,825 | 13,086 | -- | 10,697,326 | 98% | Approved | — |
Source: Lifecore Biomedical, Inc., Form 8-K, filed with the SEC on June 5, 2026 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Katrina L. Houde | 22,373,264 | 2,525,413 | -- | 62,201 | 10,786,809 | 90% | Not verified | — |
| Elect Director: Humberto C. Antunes | 24,631,549 | 247,047 | -- | 82,282 | 10,786,809 | 99.0% | Not verified | — |
| Elect Director: Paul H. Johnson | 24,772,580 | 122,686 | -- | 65,612 | 10,786,809 | 99.5% | Not verified | — |
| Elect Director: Paul Josephs | 24,847,350 | 47,427 | -- | 66,101 | 10,786,809 | 99.8% | Not verified | — |
| Elect Director: Matthew E. Korenberg | 23,547,887 | 1,347,390 | -- | 65,601 | 10,786,809 | 95% | Not verified | — |
| Elect Director: Nelson Obus | 24,351,643 | 534,854 | -- | 74,381 | 10,786,809 | 98% | Not verified | — |
| Elect Director: Joshua E. Schechter | 22,169,366 | 2,725,910 | -- | 65,602 | 10,786,809 | 89% | Not verified | — |
| 2. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, with votes | 35,663,643 | 15,326 | 68,718 | -- | -- | 99.9% | Approved | — |
| 3. The compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes | 24,642,130 | 238,354 | 80,394 | -- | 10,786,809 | 99.0% | Approved | — |
Source: Lifecore Biomedical, Inc., Form 8-K, filed with the SEC on October 31, 2025 — read the filing on EDGAR.
Each item below shows how the 128 asset managers that disclosed a Lifecore Biomedical, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Lifecore Biomedical, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held June 4, 2026.
Combines 3 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Joshua E. Schechter
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Joshua E. Schechter”): 20,394,278 for, 2,731,575 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 2,111,493 for, 614,456 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,362,898 | 4,163 | 0 | 0 | For |
| BlackRock | 507,181 | 0 | 0 | 0 | For |
| Fidelity | 0 | 445,924 | 0 | 0 | Against |
| Equitable | 99,121 | 7,490 | 0 | 0 | Mixed |
| Charles Schwab | 79,803 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 56,900 | 0 | 0 | Against |
| TIAA | 0 | 35,850 | 0 | 0 | Against |
| Lincoln Financial | 19,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,078 | 0 | 0 | 0 | For |
| Global X | 0 | 13,419 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 13,242 | 0 | 0 | Against |
| Pacific Life | 8,950 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| ProShares | 0 | 6,155 | 0 | 0 | Against |
| Voya | 0 | 4,663 | 0 | 0 | Against |
| DWS | 0 | 4,226 | 0 | 0 | Against |
| Victory Capital | 0 | 3,935 | 0 | 0 | Against |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 0 | 3,468 | 0 | 0 | Against |
| Meeder Funds | 0 | 2,873 | 0 | 0 | Against |
| SEI | 0 | 2,400 | 0 | 0 | Against |
| American Century | 0 | 2,317 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 0 | 2,286 | 0 | 0 | Against |
| Calvert | 0 | 2,087 | 0 | 0 | Against |
| Principal | 0 | 1,880 | 0 | 0 | Against |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Meeting held June 4, 2026.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Humberto C. Antunes
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Humberto C. Antunes”): 21,713,661 for, 1,408,873 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 2,656,555 for, 50,094 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,367,057 | 4 | 0 | 0 | For |
| BlackRock | 507,181 | 0 | 0 | 0 | For |
| Fidelity | 445,924 | 0 | 0 | 0 | For |
| Equitable | 99,121 | 7,490 | 0 | 0 | Mixed |
| Charles Schwab | 79,803 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 56,900 | 0 | 0 | 0 | For |
| TIAA | 0 | 35,850 | 0 | 0 | Against |
| Goldman Sachs | 19,078 | 0 | 0 | 0 | For |
| Global X | 13,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,242 | 0 | 0 | 0 | For |
| Pacific Life | 8,950 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| ProShares | 6,155 | 0 | 0 | 0 | For |
| Voya | 0 | 4,663 | 0 | 0 | Against |
| DWS | 4,226 | 0 | 0 | 0 | For |
| Victory Capital | 3,935 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 3,468 | 0 | 0 | 0 | For |
| Meeder Funds | 2,873 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| American Century | 2,317 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 2,286 | 0 | 0 | 0 | For |
| Calvert | 0 | 2,087 | 0 | 0 | Against |
| Principal | 1,880 | 0 | 0 | 0 | For |
| State Street | 1,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Meeting held June 4, 2026.
Combines 3 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Katrina L. Houde
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Katrina L. Houde”): 19,790,359 for, 3,336,694 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 2,049,501 for, 657,147 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,362,896 | 4,164 | 0 | 0 | For |
| BlackRock | 0 | 507,181 | 0 | 0 | Against |
| Fidelity | 445,724 | 200 | 0 | 0 | For |
| Equitable | 78,000 | 28,611 | 0 | 0 | Mixed |
| Charles Schwab | 79,803 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 56,900 | 0 | 0 | Against |
| TIAA | 35,850 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,078 | 0 | 0 | 0 | For |
| Global X | 13,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 13,242 | 0 | 0 | Against |
| Pacific Life | 0 | 8,950 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 7,869 | 0 | 0 | Against |
| ProShares | 0 | 6,155 | 0 | 0 | Against |
| Voya | 0 | 4,663 | 0 | 0 | Against |
| DWS | 0 | 4,226 | 0 | 0 | Against |
| Victory Capital | 0 | 3,935 | 0 | 0 | Against |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 0 | 3,468 | 0 | 0 | Against |
| Meeder Funds | 2,873 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| American Century | 0 | 2,317 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 2,286 | 0 | 0 | 0 | For |
| Calvert | 0 | 2,087 | 0 | 0 | Against |
| Principal | 0 | 1,880 | 0 | 0 | Against |
| State Street | 1,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Meeting held June 4, 2026.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Matthew E. Korenberg
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Matthew E. Korenberg”): 21,432,586 for, 1,693,825 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 2,688,131 for, 18,518 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,365,719 | 1,342 | 0 | 0 | For |
| BlackRock | 507,181 | 0 | 0 | 0 | For |
| Fidelity | 445,924 | 0 | 0 | 0 | For |
| Equitable | 99,121 | 7,490 | 0 | 0 | Mixed |
| Charles Schwab | 79,803 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 56,900 | 0 | 0 | 0 | For |
| TIAA | 35,850 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,078 | 0 | 0 | 0 | For |
| Global X | 13,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,242 | 0 | 0 | 0 | For |
| Pacific Life | 8,950 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| ProShares | 6,155 | 0 | 0 | 0 | For |
| Voya | 0 | 4,663 | 0 | 0 | Against |
| DWS | 4,226 | 0 | 0 | 0 | For |
| Victory Capital | 3,935 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 3,468 | 0 | 0 | 0 | For |
| Meeder Funds | 2,873 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| American Century | 2,317 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 2,286 | 0 | 0 | 0 | For |
| Calvert | 0 | 2,087 | 0 | 0 | Against |
| Principal | 1,880 | 0 | 0 | 0 | For |
| State Street | 0 | 1,268 | 0 | 0 | Against |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Meeting held June 4, 2026.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Nelson Obus
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Nelson Obus”): 21,450,647 for, 1,675,206 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 2,653,594 for, 53,055 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,364,238 | 2,823 | 0 | 0 | For |
| BlackRock | 507,181 | 0 | 0 | 0 | For |
| Fidelity | 445,924 | 0 | 0 | 0 | For |
| Equitable | 99,121 | 7,490 | 0 | 0 | Mixed |
| Charles Schwab | 79,803 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 56,900 | 0 | 0 | 0 | For |
| TIAA | 0 | 35,850 | 0 | 0 | Against |
| Goldman Sachs | 19,078 | 0 | 0 | 0 | For |
| Global X | 13,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,242 | 0 | 0 | 0 | For |
| Pacific Life | 8,950 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| ProShares | 6,155 | 0 | 0 | 0 | For |
| Voya | 0 | 4,663 | 0 | 0 | Against |
| DWS | 4,226 | 0 | 0 | 0 | For |
| Victory Capital | 3,935 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 3,468 | 0 | 0 | 0 | For |
| Meeder Funds | 2,873 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| American Century | 2,317 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 2,286 | 0 | 0 | 0 | For |
| Calvert | 0 | 2,087 | 0 | 0 | Against |
| Principal | 1,880 | 0 | 0 | 0 | For |
| State Street | 1,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Meeting held June 4, 2026.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Paul H. Johnson
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Paul H. Johnson”): 21,920,254 for, 1,206,182 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 2,694,492 for, 12,157 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,367,057 | 4 | 0 | 0 | For |
| BlackRock | 507,181 | 0 | 0 | 0 | For |
| Fidelity | 445,924 | 0 | 0 | 0 | For |
| Equitable | 99,121 | 7,490 | 0 | 0 | Mixed |
| Charles Schwab | 79,803 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 56,900 | 0 | 0 | 0 | For |
| TIAA | 35,850 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,078 | 0 | 0 | 0 | For |
| Global X | 13,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,242 | 0 | 0 | 0 | For |
| Pacific Life | 8,950 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| ProShares | 6,155 | 0 | 0 | 0 | For |
| Voya | 0 | 4,663 | 0 | 0 | Against |
| DWS | 4,226 | 0 | 0 | 0 | For |
| Victory Capital | 3,935 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 3,468 | 0 | 0 | 0 | For |
| Meeder Funds | 2,873 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| American Century | 2,317 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 2,286 | 0 | 0 | 0 | For |
| Calvert | 2,087 | 0 | 0 | 0 | For |
| Principal | 1,880 | 0 | 0 | 0 | For |
| State Street | 1,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Meeting held June 4, 2026.
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Paul Josephs
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Paul Josephs”): 23,068,707 for, 57,729 against, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 2,701,986 for, 4,663 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,367,061 | 0 | 0 | 0 | For |
| BlackRock | 507,181 | 0 | 0 | 0 | For |
| Fidelity | 445,924 | 0 | 0 | 0 | For |
| Equitable | 106,611 | 0 | 0 | 0 | For |
| Charles Schwab | 79,803 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 56,900 | 0 | 0 | 0 | For |
| TIAA | 35,850 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,078 | 0 | 0 | 0 | For |
| Global X | 13,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,242 | 0 | 0 | 0 | For |
| Pacific Life | 8,950 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| ProShares | 6,155 | 0 | 0 | 0 | For |
| Voya | 0 | 4,663 | 0 | 0 | Against |
| DWS | 4,226 | 0 | 0 | 0 | For |
| Victory Capital | 3,935 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 3,468 | 0 | 0 | 0 | For |
| Meeder Funds | 2,873 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| American Century | 2,317 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 2,286 | 0 | 0 | 0 | For |
| Calvert | 2,087 | 0 | 0 | 0 | For |
| Principal | 1,880 | 0 | 0 | 0 | For |
| State Street | 1,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Meeting held October 29, 2025.
Combines 4 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Matthew E. Korenberg
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Matthew E. Korenberg”): 23,547,887 for, 1,347,390 against, per its Form 8-K filed October 31, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 33 asset managers below reported 2,908,671 for, 206,624 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,223,276 | 0 | 0 | 0 | For |
| BlackRock | 795,196 | 0 | 0 | 0 | For |
| Fidelity | 567,039 | 0 | 0 | 0 | For |
| Equitable | 120,988 | 0 | 0 | 0 | For |
| Charles Schwab | 87,682 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 56,900 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 43,364 | 0 | 0 | 0 | For |
| Invesco | 0 | 33,682 | 0 | 0 | Against |
| WisdomTree | 0 | 24,621 | 0 | 0 | Against |
| TIAA | 20,595 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 19,300 | 0 | 0 | Against |
| Northern Trust | 0 | 15,876 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 14,372 | 0 | 0 | Against |
| Global X | 13,715 | 0 | 0 | 0 | For |
| Goldman Sachs | 12,200 | 0 | 0 | 0 | For |
| John Hancock | 0 | 10,582 | 0 | 0 | Against |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| Voya | 0 | 7,689 | 0 | 0 | Against |
| Nationwide | 6,557 | 0 | 0 | 0 | For |
| ProShares | 0 | 6,214 | 0 | 0 | Against |
| DWS | 0 | 4,226 | 0 | 0 | Against |
| Victory Capital | 0 | 3,652 | 0 | 0 | Against |
| Pacific Life | 3,574 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 2,595 | 0 | 0 | Against |
Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.
Meeting held October 29, 2025.
Combines 4 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Joshua E. Schechter
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Joshua E. Schechter”): 22,169,366 for, 2,725,910 against, per its Form 8-K filed October 31, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 2,006,570 for, 1,060,745 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,223,276 | 0 | 0 | 0 | For |
| BlackRock | 0 | 795,196 | 0 | 0 | Against |
| Fidelity | 567,133 | 0 | 0 | 0 | For |
| Equitable | 78,500 | 51,189 | 0 | 0 | Mixed |
| Charles Schwab | 87,682 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 43,364 | 0 | 0 | Against |
| Invesco | 33,682 | 0 | 0 | 0 | For |
| WisdomTree | 0 | 24,621 | 0 | 0 | Against |
| TIAA | 0 | 20,595 | 0 | 0 | Against |
| Lincoln Financial | 0 | 19,300 | 0 | 0 | Against |
| Northern Trust | 0 | 15,876 | 0 | 0 | Against |
| Global X | 0 | 13,715 | 0 | 0 | Against |
| Goldman Sachs | 12,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 11,221 | 0 | 0 | Against |
| John Hancock | 0 | 10,582 | 0 | 0 | Against |
| Pacific Life | 0 | 9,677 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 7,869 | 0 | 0 | Against |
| Voya | 0 | 7,689 | 0 | 0 | Against |
| Nationwide | 0 | 6,557 | 0 | 0 | Against |
| ProShares | 0 | 6,214 | 0 | 0 | Against |
| Victory Capital | 0 | 3,652 | 0 | 0 | Against |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 2,595 | 0 | 0 | Against |
| SEI | 0 | 2,400 | 0 | 0 | Against |
| Brighthouse | 0 | 2,346 | 0 | 0 | Against |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Meeting held October 29, 2025.
Combines 4 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Humberto C. Antunes
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Humberto C. Antunes”): 24,631,549 for, 247,047 against, per its Form 8-K filed October 31, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 29 asset managers below reported 3,022,477 for, 28,284 against, 7,490 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,223,276 | 0 | 0 | 0 | For |
| BlackRock | 795,196 | 0 | 0 | 0 | For |
| Fidelity | 567,039 | 0 | 0 | 0 | For |
| Equitable | 120,988 | 0 | 7,490 | 0 | Mixed |
| Charles Schwab | 87,682 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,364 | 0 | 0 | 0 | For |
| Invesco | 33,682 | 0 | 0 | 0 | For |
| WisdomTree | 24,621 | 0 | 0 | 0 | For |
| TIAA | 0 | 20,595 | 0 | 0 | Against |
| Lincoln Financial | 19,300 | 0 | 0 | 0 | For |
| Northern Trust | 15,876 | 0 | 0 | 0 | For |
| Global X | 13,715 | 0 | 0 | 0 | For |
| Goldman Sachs | 12,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,221 | 0 | 0 | 0 | For |
| John Hancock | 10,582 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| Voya | 0 | 7,689 | 0 | 0 | Against |
| Nationwide | 6,557 | 0 | 0 | 0 | For |
| ProShares | 6,214 | 0 | 0 | 0 | For |
| Victory Capital | 3,652 | 0 | 0 | 0 | For |
| Pacific Life | 3,574 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,595 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| Brighthouse | 2,346 | 0 | 0 | 0 | For |
Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.
Meeting held October 29, 2025.
Combines 4 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Katrina L. Houde
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Katrina L. Houde”): 22,373,264 for, 2,525,413 against, per its Form 8-K filed October 31, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 29 asset managers below reported 2,064,807 for, 985,954 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,223,276 | 0 | 0 | 0 | For |
| BlackRock | 0 | 795,196 | 0 | 0 | Against |
| Fidelity | 567,039 | 0 | 0 | 0 | For |
| Equitable | 78,500 | 42,488 | 0 | 0 | Mixed |
| Charles Schwab | 87,682 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 43,364 | 0 | 0 | Against |
| Invesco | 33,682 | 0 | 0 | 0 | For |
| WisdomTree | 0 | 24,621 | 0 | 0 | Against |
| TIAA | 20,595 | 0 | 0 | 0 | For |
| Lincoln Financial | 19,300 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 15,876 | 0 | 0 | Against |
| Global X | 13,715 | 0 | 0 | 0 | For |
| Goldman Sachs | 12,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 11,221 | 0 | 0 | Against |
| John Hancock | 0 | 10,582 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 7,869 | 0 | 0 | Against |
| Voya | 0 | 7,689 | 0 | 0 | Against |
| Nationwide | 0 | 6,557 | 0 | 0 | Against |
| ProShares | 0 | 6,214 | 0 | 0 | Against |
| Victory Capital | 0 | 3,652 | 0 | 0 | Against |
| Pacific Life | 0 | 3,574 | 0 | 0 | Against |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 2,595 | 0 | 0 | Against |
| SEI | 2,400 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 2,346 | 0 | 0 | Against |
Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.
Meeting held October 29, 2025.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Nelson Obus
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Nelson Obus”): 24,351,643 for, 534,854 against, per its Form 8-K filed October 31, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 29 asset managers below reported 3,022,358 for, 28,403 against, 7,490 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,223,276 | 0 | 0 | 0 | For |
| BlackRock | 795,196 | 0 | 0 | 0 | For |
| Fidelity | 567,039 | 0 | 0 | 0 | For |
| Equitable | 120,988 | 0 | 7,490 | 0 | Mixed |
| Charles Schwab | 87,682 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,364 | 0 | 0 | 0 | For |
| Invesco | 33,682 | 0 | 0 | 0 | For |
| WisdomTree | 24,621 | 0 | 0 | 0 | For |
| TIAA | 0 | 20,595 | 0 | 0 | Against |
| Lincoln Financial | 19,300 | 0 | 0 | 0 | For |
| Northern Trust | 15,876 | 0 | 0 | 0 | For |
| Global X | 13,715 | 0 | 0 | 0 | For |
| Goldman Sachs | 12,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,221 | 0 | 0 | 0 | For |
| John Hancock | 10,582 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| Voya | 0 | 7,689 | 0 | 0 | Against |
| Nationwide | 6,557 | 0 | 0 | 0 | For |
| ProShares | 6,214 | 0 | 0 | 0 | For |
| Victory Capital | 3,652 | 0 | 0 | 0 | For |
| Pacific Life | 3,574 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,595 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| Brighthouse | 2,346 | 0 | 0 | 0 | For |
Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.
Meeting held October 29, 2025.
Combines 4 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Paul H. Johnson
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Paul H. Johnson”): 24,772,580 for, 122,686 against, per its Form 8-K filed October 31, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 29 asset managers below reported 3,056,770 for, 7,689 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,223,276 | 0 | 0 | 0 | For |
| BlackRock | 795,196 | 0 | 0 | 0 | For |
| Fidelity | 567,039 | 0 | 0 | 0 | For |
| Equitable | 134,686 | 0 | 0 | 0 | For |
| Charles Schwab | 87,682 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,364 | 0 | 0 | 0 | For |
| Invesco | 33,682 | 0 | 0 | 0 | For |
| WisdomTree | 24,621 | 0 | 0 | 0 | For |
| TIAA | 20,595 | 0 | 0 | 0 | For |
| Lincoln Financial | 19,300 | 0 | 0 | 0 | For |
| Northern Trust | 15,876 | 0 | 0 | 0 | For |
| Global X | 13,715 | 0 | 0 | 0 | For |
| Goldman Sachs | 12,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,221 | 0 | 0 | 0 | For |
| John Hancock | 10,582 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| Voya | 0 | 7,689 | 0 | 0 | Against |
| Nationwide | 6,557 | 0 | 0 | 0 | For |
| ProShares | 6,214 | 0 | 0 | 0 | For |
| Victory Capital | 3,652 | 0 | 0 | 0 | For |
| Pacific Life | 3,574 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,595 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| Brighthouse | 2,346 | 0 | 0 | 0 | For |
Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.
Meeting held October 29, 2025.
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Paul Josephs
Lifecore Biomedical, Inc.’s own tally for this item (“Elect Director: Paul Josephs”): 24,847,350 for, 47,427 against, per its Form 8-K filed October 31, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 29 asset managers below reported 3,043,072 for, 7,689 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,223,276 | 0 | 0 | 0 | For |
| BlackRock | 795,196 | 0 | 0 | 0 | For |
| Fidelity | 567,039 | 0 | 0 | 0 | For |
| Equitable | 120,988 | 0 | 0 | 0 | For |
| Charles Schwab | 87,682 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,364 | 0 | 0 | 0 | For |
| Invesco | 33,682 | 0 | 0 | 0 | For |
| WisdomTree | 24,621 | 0 | 0 | 0 | For |
| TIAA | 20,595 | 0 | 0 | 0 | For |
| Lincoln Financial | 19,300 | 0 | 0 | 0 | For |
| Northern Trust | 15,876 | 0 | 0 | 0 | For |
| Global X | 13,715 | 0 | 0 | 0 | For |
| Goldman Sachs | 12,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,221 | 0 | 0 | 0 | For |
| John Hancock | 10,582 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| Voya | 0 | 7,689 | 0 | 0 | Against |
| Nationwide | 6,557 | 0 | 0 | 0 | For |
| ProShares | 6,214 | 0 | 0 | 0 | For |
| Victory Capital | 3,652 | 0 | 0 | 0 | For |
| Pacific Life | 3,574 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,595 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| Brighthouse | 2,346 | 0 | 0 | 0 | For |
Showing the 25 largest of 29 asset managers. See all 29 in the interactive database.
Meeting held October 29, 2025.
100% of fund votes cast · no official result
The 8 asset managers below reported 82,716 for, 857,011 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 795,196 | 0 | Abstain |
| Equitable | 78,500 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 43,364 | 0 | Abstain |
| John Hancock | 0 | 0 | 10,582 | 0 | Abstain |
| Bridge Builder Trust | 0 | 0 | 7,869 | 0 | Abstain |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 597 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 119 | 0 | 0 | 0 | For |
Meeting held June 4, 2026.
Combines 2 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: TO APPROVE THE LIFECORE BIOMEDICAL, INC. 2026 STOCK INCENTIVE PLAN.
Lifecore Biomedical, Inc.’s own tally for this item (“4.Stockholders approved the Lifecore Biomedical, Inc.”): 22,724,492 for, 392,825 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “4.Stockholders approved the Lifecore Biomedical, Inc. 2026 Stock Incentive Plan, with votes as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,367,060 | 1 | 0 | 0 | For |
| BlackRock | 507,181 | 0 | 0 | 0 | For |
| Fidelity | 445,924 | 0 | 0 | 0 | For |
| Equitable | 28,611 | 78,000 | 0 | 0 | Mixed |
| Charles Schwab | 79,803 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 56,900 | 0 | 0 | 0 | For |
| TIAA | 35,850 | 0 | 0 | 0 | For |
| Lincoln Financial | 19,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,078 | 0 | 0 | 0 | For |
| Global X | 13,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,242 | 0 | 0 | 0 | For |
| Pacific Life | 8,950 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| ProShares | 6,155 | 0 | 0 | 0 | For |
| Voya | 4,663 | 0 | 0 | 0 | For |
| DWS | 4,226 | 0 | 0 | 0 | For |
| Victory Capital | 3,935 | 0 | 0 | 0 | For |
| Gabelli | 0 | 3,500 | 0 | 0 | Against |
| John Hancock | 3,468 | 0 | 0 | 0 | For |
| Meeder Funds | 2,873 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| American Century | 0 | 2,317 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 2,286 | 0 | 0 | 0 | For |
| Calvert | 2,087 | 0 | 0 | 0 | For |
| Principal | 1,880 | 0 | 0 | 0 | For |
Fund voting reports, all 36 managers: 2,641,395 for, 84,554 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Legion Partners Asset Management, LLC | 4,403,754 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 4,403,754 for.
Meeting held June 4, 2026.
Combines 4 wordings of this item as funds reported it.
99.2% Approved · of votes cast
Description as filed by funds: To approve a non-binding advisory proposal on the executive compensation of the Company's named executive officers, as described in the Proxy Statement.
Lifecore Biomedical, Inc.’s own tally for this item (“3. The compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes”): 22,938,684 for, 178,868 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes as follows:”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,367,061 | 0 | 0 | 0 | For |
| BlackRock | 507,181 | 0 | 0 | 0 | For |
| Fidelity | 445,924 | 0 | 0 | 0 | For |
| Equitable | 106,611 | 0 | 0 | 0 | For |
| Charles Schwab | 79,803 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 56,900 | 0 | 0 | 0 | For |
| TIAA | 35,850 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,078 | 0 | 0 | 0 | For |
| Global X | 13,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,242 | 0 | 0 | 0 | For |
| Pacific Life | 8,950 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| ProShares | 6,155 | 0 | 0 | 0 | For |
| FORUM FUNDS | 5,000 | 0 | 0 | 0 | For |
| Voya | 4,663 | 0 | 0 | 0 | For |
| DWS | 4,226 | 0 | 0 | 0 | For |
| Victory Capital | 3,935 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 3,468 | 0 | 0 | 0 | For |
| Meeder Funds | 2,873 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| American Century | 0 | 2,317 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 2,286 | 0 | 0 | 0 | For |
| Calvert | 0 | 2,087 | 0 | 0 | Against |
| Principal | 1,880 | 0 | 0 | 0 | For |
Fund voting reports, all 36 managers: 2,707,233 for, 4,416 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC | 4,439,840 | 0 | 0 | 0 | For |
| Legion Partners Asset Management, LLC | 4,403,754 | 0 | 0 | 0 | For |
| 325 CAPITAL LLC | 2,161,212 | 0 | 0 | 0 | For |
| BlackRock | 697,086 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 566,605 | 0 | 0 | 0 | For |
| State Street | 337,938 | 0 | 0 | 0 | For |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 299,415 | 0 | 0 | 0 | For |
| Vanguard | 255,943 | 0 | 0 | 0 | For |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 151,700 | 0 | 0 | 0 | For |
| Northern Trust | 116,700 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 103,568 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 83,168 | 0 | 0 | Against |
| Gabelli | 82,500 | 0 | 0 | 0 | For |
| Charles Schwab | 79,972 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 61,800 | 0 | 0 | 0 | For |
| Nuveen | 35,850 | 0 | 0 | 0 | For |
| West Tower Group, LLC | 35,424 | 0 | 0 | 0 | For |
| Goldman Sachs | 28,913 | 0 | 0 | 0 | For |
| T. Rowe Price | 28,176 | 0 | 0 | 0 | For |
| Corient Private Wealth LP | 27,789 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 19,366 | 0 | 0 | 0 | For |
| Diversified Trust Co | 18,146 | 0 | 0 | 0 | For |
| Rhumbline | 11,716 | 0 | 0 | 0 | For |
| Invesco | 0 | 9,788 | 0 | 0 | Against |
| AllianceBernstein | 9,680 | 0 | 0 | 0 | For |
Institutional-manager reports, all 84 managers: 14,053,733 for, 104,420 against. Showing the 25 largest; see all in the interactive database.
Meeting held October 29, 2025.
Combines 4 wordings of this item as funds reported it.
99.0% Approved · of votes cast
Description as filed by funds: To approve a non-binding advisory proposal on the executive compensation of the Company's named executive officers, as described in the Proxy Statement.
Lifecore Biomedical, Inc.’s own tally for this item (“3. The compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes”): 24,642,130 for, 238,354 against — passed, per its Form 8-K filed October 31, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes as follows:”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,223,276 | 0 | 0 | 0 | For |
| BlackRock | 795,196 | 0 | 0 | 0 | For |
| Fidelity | 567,039 | 0 | 0 | 0 | For |
| Equitable | 120,988 | 0 | 0 | 0 | For |
| Charles Schwab | 69,255 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,364 | 0 | 0 | 0 | For |
| Invesco | 0 | 33,682 | 0 | 0 | Against |
| WisdomTree | 0 | 24,621 | 0 | 0 | Against |
| TIAA | 20,595 | 0 | 0 | 0 | For |
| Lincoln Financial | 19,300 | 0 | 0 | 0 | For |
| Northern Trust | 15,876 | 0 | 0 | 0 | For |
| Global X | 13,715 | 0 | 0 | 0 | For |
| Goldman Sachs | 12,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,221 | 0 | 0 | 0 | For |
| John Hancock | 10,582 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| Voya | 7,689 | 0 | 0 | 0 | For |
| Nationwide | 6,557 | 0 | 0 | 0 | For |
| ProShares | 6,214 | 0 | 0 | 0 | For |
| FORUM FUNDS | 5,000 | 0 | 0 | 0 | For |
| Victory Capital | 3,652 | 0 | 0 | 0 | For |
| Pacific Life | 3,574 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,595 | 0 | 0 | 0 | For |
| Brighthouse | 2,346 | 0 | 0 | 0 | For |
Fund voting reports, all 30 managers: 2,978,718 for, 58,303 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC | 4,699,779 | 0 | 0 | 0 | For |
| 325 CAPITAL LLC | 1,369,154 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 623,996 | 0 | 0 | 0 | For |
| BlackRock | 599,097 | 0 | 0 | 0 | For |
| State Street | 458,350 | 0 | 0 | 0 | For |
| Northern Trust | 139,018 | 0 | 0 | 0 | For |
| Charles Schwab | 87,687 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 84,239 | 0 | 0 | 0 | For |
| Gabelli | 83,000 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 76,308 | 0 | 0 | Against |
| Vanguard | 63,312 | 0 | 0 | 0 | For |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 0 | 0 | 50,337 | 0 | Abstain |
| Invesco | 0 | 36,666 | 0 | 0 | Against |
| Citadel | 34,633 | 0 | 0 | 0 | For |
| T. Rowe Price | 27,640 | 0 | 0 | 0 | For |
| Nuveen | 20,595 | 0 | 0 | 0 | For |
| Diversified Trust Co | 18,146 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,520 | 0 | 0 | 0 | For |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 0 | 17,223 | 0 | 0 | Against |
| John Hancock | 10,629 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 10,552 | 0 | 0 | 0 | For |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 0 | 10,463 | 0 | 0 | Against |
| Corient Private Wealth LP | 10,322 | 0 | 0 | 0 | For |
| State of Wyoming | 8,432 | 0 | 0 | 0 | For |
| Voya | 7,689 | 0 | 0 | 0 | For |
Institutional-manager reports, all 72 managers: 8,432,755 for, 143,969 against, 56,435 abstained. Showing the 25 largest; see all in the interactive database.
Meeting held June 4, 2026.
99.8% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2026.
Lifecore Biomedical, Inc.’s own tally for this item (“2. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026, with votes”): 33,760,879 for, 63,445 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026, with votes as follows:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 2,725,949 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,367,061 | 0 | 0 | 0 | For |
| BlackRock | 507,181 | 0 | 0 | 0 | For |
| Fidelity | 445,924 | 0 | 0 | 0 | For |
| Equitable | 106,611 | 0 | 0 | 0 | For |
| Charles Schwab | 79,803 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 56,900 | 0 | 0 | 0 | For |
| TIAA | 35,850 | 0 | 0 | 0 | For |
| Lincoln Financial | 19,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 19,078 | 0 | 0 | 0 | For |
| Global X | 13,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,242 | 0 | 0 | 0 | For |
| Pacific Life | 8,950 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| ProShares | 6,155 | 0 | 0 | 0 | For |
| Voya | 4,663 | 0 | 0 | 0 | For |
| DWS | 4,226 | 0 | 0 | 0 | For |
| Victory Capital | 3,935 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| John Hancock | 3,468 | 0 | 0 | 0 | For |
| Meeder Funds | 2,873 | 0 | 0 | 0 | For |
| SEI | 2,400 | 0 | 0 | 0 | For |
| American Century | 2,317 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 2,286 | 0 | 0 | 0 | For |
| Calvert | 2,087 | 0 | 0 | 0 | For |
| Principal | 1,880 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Meeting held October 29, 2025.
99.9% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
Lifecore Biomedical, Inc.’s own tally for this item (“2. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, with votes”): 35,663,643 for, 15,326 against — passed, per its Form 8-K filed October 31, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, with votes as follows:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 3,157,689 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,240,939 | 0 | 0 | 0 | For |
| BlackRock | 795,196 | 0 | 0 | 0 | For |
| Fidelity | 567,133 | 0 | 0 | 0 | For |
| Equitable | 135,779 | 0 | 0 | 0 | For |
| Charles Schwab | 87,682 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 56,900 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 43,364 | 0 | 0 | 0 | For |
| Invesco | 33,682 | 0 | 0 | 0 | For |
| WisdomTree | 24,621 | 0 | 0 | 0 | For |
| TIAA | 20,595 | 0 | 0 | 0 | For |
| Lincoln Financial | 19,300 | 0 | 0 | 0 | For |
| Northern Trust | 15,876 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,372 | 0 | 0 | 0 | For |
| Global X | 13,715 | 0 | 0 | 0 | For |
| Goldman Sachs | 12,200 | 0 | 0 | 0 | For |
| John Hancock | 10,582 | 0 | 0 | 0 | For |
| Pacific Life | 9,677 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,869 | 0 | 0 | 0 | For |
| Voya | 7,689 | 0 | 0 | 0 | For |
| Nationwide | 6,557 | 0 | 0 | 0 | For |
| ProShares | 6,214 | 0 | 0 | 0 | For |
| DWS | 4,226 | 0 | 0 | 0 | For |
| Victory Capital | 3,652 | 0 | 0 | 0 | For |
| Gabelli | 3,500 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,595 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 37,509,407 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.64% |
| 2 | BlackRock | 1.35% |
| 3 | Fidelity | 1.19% |
| 4 | Equitable | 0.28% |
| 5 | Charles Schwab | 0.21% |
| 6 | BRIDGEWAY FUNDS INC | 0.15% |
| 7 | TIAA | 0.10% |
| 8 | Goldman Sachs | 0.05% |
| 9 | Global X | 0.04% |
| 10 | AIG/SunAmerica | 0.04% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | WYNNEFIELD CAPITAL INC | 11.84% |
| 2 | Legion Partners Asset Management, LLC | 11.74% |
| 3 | 325 CAPITAL LLC | 5.76% |
| 4 | BlackRock | 1.86% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.51% |
| 6 | State Street | 0.90% |
| 7 | WITTENBERG INVESTMENT MANAGEMENT, INC. | 0.80% |
| 8 | Vanguard | 0.68% |
| 9 | TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.40% |
| 10 | Northern Trust | 0.31% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Christopher S. Kiper | 18.38% | DEF14A |
| Legion Partners, LLC | 17.91% | 13D |
| Nelson Obus | 14.54% | DEF14A |
| Wynnefield Capital, Inc. | 14.54% | DEF14A |
| Greenhaven Road Investment Management, LP | 9.64% | DEF14A |
| 22NW, LP | 8.49% | DEF14A |
| Capital | 8.36% | DEF14A |
| 22NW Fund, LP | 7.23% | 13D |
| LW Capital Management | 5.07% | DEF14A |
| BlackRock | 5.00% | 13F |
Percentages above are of 37,509,407 shares outstanding, as reported by Lifecore Biomedical, Inc. on its Form 10-Q dated April 29, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Lifecore Biomedical, Inc.’s 10-Q dated April 29, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At Lifecore Biomedical, Inc.'s 2 shareholder meetings in the 2025-2026 proxy season (held October 29, 2025 and June 4, 2026), 128 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,893 separate fund positions. Their filings are grouped here into 20 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held June 4, 2026 — To approve a non-binding advisory proposal on the executive compensation of the Company's named… — Lifecore Biomedical, Inc.'s filing reports the proposal as approved, with 99.2% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Lifecore Biomedical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2026.
Lifecore Biomedical, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.